Differences and correlation of serum CEA, CA19-9 and CA72-4 in gastric cancer
Health Screening – Raised Cancer Markers CEA, Ca 19-9 and aFP
CA19-9 for detecting recurrence of pancreatic cancer | Scientific Reports
Past, Present, and Future of Serum Tumor Markers in Management of Ovarian Cancer: A Guide for the Radiologist | RadioGraphics
Gene Variants That Affect Levels of Circulating Tumor Markers Increase Identification of Patients With Pancreatic Cancer
A genome wide association study of genetic loci that influence tumour biomarkers cancer antigen 19-9, carcinoembryonic antigen and α fetoprotein and their associations with cancer risk | Gut
Evaluating the efficacy of tumor markers CA 19-9 and CEA to predict operability and survival in pancreatic malignancies
CEA but not CA19-9 is an independent prognostic factor in patients undergoing resection of cholangiocarcinoma | Scientific Reports
Clinical Utility of Tumor Markers
CA 19-9 in Patients with Pulmonary Fibrosis Department of Rheumatology Doohyun Woo. - ppt download
CA 19-9 and CA 125 as potential predictors of disease recurrence in resectable lung adenocarcinoma | PLOS ONE
Limited usefulness of serum carcinoembryonic antigen and carbohydrate antigen 19-9 levels for gastrointestinal and whole-body cancer screening | Scientific Reports
Correlation Between Serum Tumor Marker Levels and Connective Tissue Di | IJGM
CA 19-9 tumor marker | pancreatic cancer diagnosis | tumor marker (Everything you need to know) - YouTube
Comparison of two immunoassays for CA19-9, CEA and AFP tumor markers - Biochemia Medica
Combined Evaluation of AFP, CA15-3, CA125, CA19-9, and CEA Tumor Markers in Patients with Hepatitis B and C | Semantic Scholar
Extremely high serum level of carbohydrate antigen 19-9 in a patient with colon adenocarcinoma
Clinical significance and diagnostic value of serum NSE, CEA, CA19‑9, CA125 and CA242 levels in colorectal cancer
CA 19-9 As a Marker in Addition to CEA to Monitor Colorectal Cancer - ScienceDirect
Clinical Performance of CEA, CA19-9, CA15-3, CA125 and AFP in Gastrointestinal Cancer Using LOCI™-based Assays | Anticancer Research
CA19-9 Levels in Saliva and Urine of Patients with Ductal Adenocarcinoma of the Pancreas Correlates with Serum CA19-9 Levels - A Prospective Preliminary Study
CEA+CA19-9 in gastric cancer. Figure 3 CEA+CA19-9 in colon cancer. | Download Scientific Diagram
Full article: Elevated CEA and CA19-9 serum levels independently predict advanced pancreatic cancer at diagnosis
Comparison of mean CEA and CA19-9 values by tumor type | Download Table
